Optimizing education for dermatology residents during the COVID-19 pandemic - 08/09/20

| Funding sources: None. |
|
| Conflicts of interest: Dr Guzman discloses the receipt of travel reimbursement from Verrica Pharmaceuticals, consulting fees from Cello Health, and advisory board participation with Janssen. Drs Patel, McLellan, and Blasiak have no conflicts of interest to disclose. |
|
| IRB approval status: Institutional Review Board approval was not required. |
|
| Reprints not available from the authors. |
Vol 83 - N° 4
P. e319-e320 - octobre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
